1. Home
  2. ARCT vs BLDE Comparison

ARCT vs BLDE Comparison

Compare ARCT & BLDE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARCT
  • BLDE
  • Stock Information
  • Founded
  • ARCT 2013
  • BLDE 2014
  • Country
  • ARCT United States
  • BLDE United States
  • Employees
  • ARCT N/A
  • BLDE N/A
  • Industry
  • ARCT Biotechnology: Pharmaceutical Preparations
  • BLDE Aerospace
  • Sector
  • ARCT Health Care
  • BLDE Consumer Discretionary
  • Exchange
  • ARCT Nasdaq
  • BLDE Nasdaq
  • Market Cap
  • ARCT 298.3M
  • BLDE 285.2M
  • IPO Year
  • ARCT N/A
  • BLDE N/A
  • Fundamental
  • Price
  • ARCT $13.91
  • BLDE $3.74
  • Analyst Decision
  • ARCT Strong Buy
  • BLDE Strong Buy
  • Analyst Count
  • ARCT 8
  • BLDE 2
  • Target Price
  • ARCT $52.33
  • BLDE $6.25
  • AVG Volume (30 Days)
  • ARCT 473.8K
  • BLDE 772.1K
  • Earning Date
  • ARCT 08-04-2025
  • BLDE 08-06-2025
  • Dividend Yield
  • ARCT N/A
  • BLDE N/A
  • EPS Growth
  • ARCT N/A
  • BLDE N/A
  • EPS
  • ARCT N/A
  • BLDE N/A
  • Revenue
  • ARCT $143,680,000.00
  • BLDE $251,485,000.00
  • Revenue This Year
  • ARCT N/A
  • BLDE $5.58
  • Revenue Next Year
  • ARCT $34.79
  • BLDE $8.56
  • P/E Ratio
  • ARCT N/A
  • BLDE N/A
  • Revenue Growth
  • ARCT 15.38
  • BLDE 8.67
  • 52 Week Low
  • ARCT $8.04
  • BLDE $2.35
  • 52 Week High
  • ARCT $27.54
  • BLDE $5.17
  • Technical
  • Relative Strength Index (RSI)
  • ARCT 58.02
  • BLDE 52.70
  • Support Level
  • ARCT $12.03
  • BLDE $3.57
  • Resistance Level
  • ARCT $13.42
  • BLDE $3.90
  • Average True Range (ATR)
  • ARCT 0.77
  • BLDE 0.20
  • MACD
  • ARCT 0.05
  • BLDE -0.05
  • Stochastic Oscillator
  • ARCT 82.12
  • BLDE 27.91

About ARCT Arcturus Therapeutics Holdings Inc.

Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on opportunities in rare diseases with a current focus on liver and respiratory diseases. It operates in one business segment, which includes all activities related to the discovery, development and commercialization of messenger RNA medicines. The company's pipeline includes LUNAR-OTC, LUNAR-CF, LUNAR-FLU, and LUNAR-COV19.

About BLDE Blade Air Mobility Inc.

Blade Air Mobility Inc is a technology-powered air mobility platform that provides air transportation and logistics for hospitals and is a transporter of human organs for transplant, and for passengers, with helicopter and fixed-wing services predominantly in the Northeast United States, Southern Europe and Western Canada. The company's operating segments are; Passenger, and Medical. Majority of the revenue for the company is generated from its Medical segment which predominantly consists of transportation of human organs for transplant and the medical teams supporting these services. It also offers additional services including donor logistics coordination and support in evaluating potential donor organs. A substantial portion of the company's revenue is generated from the United States.

Share on Social Networks: